| Price | 124.40p on 25-02-2026 at 06:00:10 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.00p |
| Sell | 120.00p |
| Last Trade: | Sell 2,026.00 at 124.722p |
| Day's Volume: | 0 |
| Last Close: | 124.40p |
| Open: | 0.00p |
| ISIN: | GB00BY2Z0H74 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 100.40p - 148.00p |
| Market Capitalisation: | £300.65m |
| VWAP: | 0.00p |
| Shares in Issue: | 241.68m |
PureTech (PRTC) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 2,026 | 124.722p | SI Trade Suspected SELL Trade |
16:47:04 - 24-Feb-26 |
| Buy* | 2,895 | 124.40p | Automatic Execution |
16:38:59 - 24-Feb-26 |
| Buy* | 19,802 | 124.40p | Automatic Execution |
16:38:59 - 24-Feb-26 |
| Buy* | 75,080 | 124.40p | Suspected BUY Trade |
16:35:13 - 24-Feb-26 |
| Sell* | 656 | 124.40p | Automatic Execution |
16:29:10 - 24-Feb-26 |
| Sell* | 368 | 124.40p | Automatic Execution |
16:29:10 - 24-Feb-26 |
| Sell* | 2,000 | 124.58p | Ordinary |
16:23:32 - 24-Feb-26 |
| Buy* | 690 | 124.60p | Automatic Execution |
16:18:25 - 24-Feb-26 |
| Buy* | 71 | 124.60p | Automatic Execution |
16:18:25 - 24-Feb-26 |
| Buy* | 12 | 124.60p | Automatic Execution |
16:18:25 - 24-Feb-26 |
PureTech (PRTC) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 19th Feb 2026 5:15 pm | RNS-R | PRTC's Deupirfenidone Granted FDA & EU ODD for IPF |
| 6th Jan 2026 12:00 pm | RNS-R | PureTech to Present at the JP Morgan Conference |
| 18th Dec 2025 7:00 am | RNS | PureTech Appoints Robert Lyne as CEO |
| 10th Dec 2025 5:41 pm | RNS | Results of AGM on June 16, 2025 – Update Statement |
| 10th Dec 2025 5:30 pm | RNS | Holding(s) in Company |
| 8th Dec 2025 7:00 am | RNS-R | PRTC: Successful FDA Meeting; IPF Phase 3 in 1H26 |
| 5th Dec 2025 6:00 pm | RNS-R | PRTC's Gallop: Positive Initial Topline AML Data |
| 18th Nov 2025 5:30 pm | RNS | Holding(s) in Company |
| 7th Nov 2025 6:18 pm | RNS | Holding(s) in Company |
| 3rd Nov 2025 2:00 pm | RNS-R | PRTC: New LYT-200 AML Data + Update at ASH |
